Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!

F Sanfilippo¹, V La Rosa², F Oliveri³, M Astuto^{3

2

4}

Affiliations

¹ Department of Anaesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele", Catania, Italy. filipposanfi@yahoo.it.
² School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico", University of Catania, Catania, Italy.
³ Department of Anaesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele", Catania, Italy.
⁴ Department of General Surgery and Medical-Surgical Specialties, Section of Anesthesia and Intensive Care, University of Catania, Catania, Italy.

Comment

F Sanfilippo et al. Crit Care. 2020.

. 2020 Aug 28;24(1):531.

doi: 10.1186/s13054-020-03236-3.

F Sanfilippo¹, V La Rosa², F Oliveri³, M Astuto^{3

2

4}

¹ Department of Anaesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele", Catania, Italy. filipposanfi@yahoo.it.
² School of Anaesthesia and Intensive Care, University Hospital "G. Rodolico", University of Catania, Catania, Italy.
³ Department of Anaesthesia and Intensive Care, A.O.U. "Policlinico-Vittorio Emanuele", Catania, Italy.
⁴ Department of General Surgery and Medical-Surgical Specialties, Section of Anesthesia and Intensive Care, University of Catania, Catania, Italy.

No abstract available

Conflict of interest statement

The authors declare that they have no competing interests.

Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials.
Shankar-Hari M, Estcourt L, Harvala H, Roberts D, Menon DK; United Kingdom SARS-CoV-2 Convalescent Plasma Evaluation (SCoPE) Consortium. Shankar-Hari M, et al. Crit Care. 2020 Jul 20;24(1):449. doi: 10.1186/s13054-020-03163-3. Crit Care. 2020. PMID: 32690059 Free PMC article. No abstract available.

1. Shankar-Hari M, Estcourt L, Harvala H, Roberts D, Menon DK, Shankar-Hari M, et al. Convalescent plasma to treat critically ill patients with COVID-19: framing the need for randomised clinical trials. Crit Care. 2020;24(1):449. doi: 10.1186/s13054-020-03163-3. - DOI - PMC - PubMed
1. Julien P, Julien G, Morgan C, Erika P, Thibault D, Fanny L, et al. Pulmonary embolism in patients with COVID-19. Circulation. 2020;142(2):184–186. doi: 10.1161/CIRCULATIONAHA.120.047430. - DOI - PubMed
1. Lozano M, Cid J, Müller TH. Plasma treated with methylene blue and light: clinical efficacy and safety profile. Transfus Med Rev. 2013;27(4):235–240. doi: 10.1016/j.tmrv.2013.08.001. - DOI - PubMed
1. Joyner MJ, Wright RS, Fairweather D, Senefeld JW, Bruno KA, Klassen SA, et al. Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. J Clin Invest. 2020. https://www.jci.org/articles/view/140200, https://pubmed.ncbi.nlm.nih.gov/32525844/. - PMC - PubMed
1. Xu Z, Zhou J, Huang Y, Liu X, Xu Y, Chen S, et al. Efficacy of convalescent plasma for the treatment of severe influenza. Crit Care. 2020;24(1):469. doi: 10.1186/s13054-020-03189-7. - DOI - PMC - PubMed